PHARMACOLOGY OF COMBINED ALPHA-BETA-BLOCKADE .2. HEMODYNAMIC-EFFECTS OF LABETALOL

被引:66
作者
LUNDJOHANSEN, P
机构
关键词
D O I
10.2165/00003495-198400282-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:35 / 50
页数:16
相关论文
共 46 条
[1]   THE ACUTE AND CHRONIC HYPOTENSIVE EFFECT OF LABETALOL AND THE RELATIONSHIP WITH PRETREATMENT PLASMA NORADRENALINE LEVELS [J].
AGABITIROSEI, E ;
ALICANDRI, CL ;
BESCHI, M ;
CASTELLANO, M ;
FARIELLO, R ;
MONTINI, E ;
MUIESAN, ML ;
ROMANELLI, G ;
MUIESAN, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S87-S92
[2]  
AGABITIROSEI E, 1976, AUST NZ J MED, V6, P83
[3]  
ATTERHOG JH, 1977, ACTA MED SCAND, P55
[4]   EFFECT OF AN ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR-BLOCKING AGENT (LABETALOL) ON HEMODYNAMICS IN HYPERTENSION [J].
BAHLMANN, J ;
BROD, J ;
HUBRICH, W ;
CACHOVAN, M ;
PRETSCHNER, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S113-S117
[5]  
BIRKENHAGER WH, 1982, CONTROL MECHANISMS E
[6]   ROLE OF BETA-ADRENERGIC-BLOCKADE IN THE THERAPY OF PATIENTS WITH MYOCARDIAL-INFARCTION [J].
BRAUNWALD, E ;
MULLER, JE ;
KLONER, RA ;
MAROKO, PR .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (01) :113-123
[7]   LABETALOL - REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN HYPERTENSION [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1978, 15 (04) :251-270
[8]  
BUHLER FR, 1982, HYPERTENSIVE CARDIOV, P164
[9]   A REVIEW OF THE HEMODYNAMIC-EFFECTS OF LABETALOL IN MAN [J].
COHN, JN ;
MEHTA, J ;
FRANCIS, GS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S19-S26
[10]   INTRAVENOUS LABETALOL IN THE TREATMENT OF SEVERE HYPERTENSION [J].
CUMMING, AMM ;
BROWN, JJ ;
LEVER, AF ;
ROBERTSON, JIS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S93-S96